Eksigent has announced plans to increase manufacturing capacity by 40 per cent to meet demand for its HPLC products.
In particular there has been an increase in demand for the cHiPLC-nanoflex for proteomics and ExpressHT-Ultra HPLC system for ADME-Tox and DMPK studies.
The new cHiPLC-nanoflex system is a docking station for up to three microfluidic chips that contain nanoLC or trap columns.
The system delivers improved reproducibility and ease of use to proteomics research.
The ExpressHT-Ultra HPLC system is the latest offering in Eksigent's line of products for small molecule analysis.
It provides short cycle times and high throughput for LC/MS studies of pharmacokinetics and drug metabolism.
